A Systematic Evaluation of the SARS-CoV-2 Vaccine-Induced Anti-S-RBD-Ig Response in a Population of Health Care Workers
In the wake of the COVID-19 pandemic, the novel class of mRNA vaccines has been granted first-time approval for active immunization against SARS-CoV-2 alongside the already established viral vector-based vaccines. In this prospective single-center study, we set out to determine the vaccine-induced h...
Main Authors: | Viktoria Hentschel, Cornelia Horsch, Benjamin Mayer, Annsophie Thies, Will Qian, Joris Kroschel, Thomas Seufferlein, Lukas Perkhofer, Martin Müller |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/9/1467 |
Similar Items
-
IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study
by: Sergio Gil-Manso, et al.
Published: (2022-11-01) -
Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination
by: Andrzej Tretyn, et al.
Published: (2021-07-01) -
Long-term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers
by: Joana Oliveira-Silva, et al.
Published: (2022-09-01) -
Heterologous high dose SARS-CoV-2 mRNA vaccine booster may improve immune response in seronegative kidney transplant recipients
by: Leszek Tylicki, et al.
Published: (2022-06-01) -
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients
by: Chiara Pellicano, et al.
Published: (2022-08-01)